Field efficacy of the insect growth regulator dicyclanil for flystrike prevention on lambs.

A multi-centered field trial was carried out in the Netherlands to evaluate the efficacy of a ready-to-use 5% dicyclanil formulation as a preventative of natural flystrike on lambs. In four different sites a total of 1215 lambs treated with dicyclanil were compared with 431 untreated lambs during periods of 15 to 16 weeks. Efficacy was assessed by calculating the weekly cumulative strike rate for each site and treatment group and the percentage reduction achieved by dicyclanil. In two of the four sites untreated controls did not receive enough fly challenge and were not considered for efficacy assessment. At the other two sites untreated controls reached cumulative strike rates of 10.5 and 19.5% 15 and 16 weeks after treatment, respectively. None of the 549 lambs treated with dicyclanil at these two sites were struck, resulting in a 100% reduction of flystrike during the whole length of the trial.     

Prevention of blowfly strike on coarse and fine woolled sheep with the insect growth regulator dicyclanil

OBJECTIVE: To assess a ready-to-use formulation of dicyclanil to prevent blowfly strike on coarse and fine woolled sheep under New Zealand conditions. DESIGN: Randomized clinical field trials. PROCEDURE: In a first field trial, coarse wooled sheep treated with a ready-to-use, 5% dicyclanil formulation were compared with untreated control sheep for up to 21 weeks. In a second field trial, fine woolled sheep, treated with the same dicyclanil formulation, were compared with untreated sheep for up to 19 weeks. Efficacy was assessed by calculating the aggregated cumulative strike rate. RESULTS: For trial 1 (coarse woolled sheep) the aggregated cumulative strike rate at the end of the trial at week 21 after treatment reached 3.9% and 19.1% for treated and untreated sheep, respectively. For the treated animals the aggregated cumulative strike rate reached the 1% and 2% benchmarks between weeks 11 and 12. For trial 2 (fine woolled sheep) the aggregated cumulative strike rate at the end of the trial at week 19 reached 0.6% and 7.5% for treated and untreated sheep, respectively. Wool length at the time of application did not substantially influence the efficacy of dicyclanil. CONCLUSION: Under New Zealand field conditions, a ready-to-use 5% spray-on formulation of dicyclanil protected coarse woolled sheep for at least 12 weeks and fine woolled sheep for at least 19 weeks.     

Prevention of blowfly strike on lambs with the insect growth regulator dicyclanil

In three multicentered field trials run during 1995 to 1997, involving a total of 12,928 lambs, the preventive effects on blowfly strike of a ready-to-use 5 per cent dicyclanil pour-on formulation and of a ready-to-use 6 per cent cyromazine pour-on formulation were compared with untreated controls for periods of up to 22 weeks. Their efficacy was assessed by calculating the consolidated cumulative strike rate for each treatment group and the consolidated percentage reduction of flystrike achieved by the two formulations. The consolidated cumulative strike rate for all three years together reached 29.2 per cent for the untreated control lambs at week 22, 2.8 per cent for the dicyclanil-treated lambs at week 22, and 6.9 per cent for the cyromazine-treated lambs at week 20. The consolidated cumulative percentage reduction of blowfly strike remained above 89 per cent for the dicyclanil-treated lambs. For the cyromazine-treated lambs the consolidated cumulative percentage reduction of blowfly strike reached 90 per cent during weeks 9 to 10, and 80 per cent during weeks 11 to 12.     

Long-lasting prevention against blowfly strike using the insect growth regulator dicyclanil

OBJECTIVE: To assess a ready-to-use formulation of dicyclanil to prevent blowfly strike on Merino sheep under Australian conditions. DESIGN: Randomised clinical trials conducted in an environment house and in the field. PROCEDURE: Two environment house trials were used to measure the protection against flystrike provide by a jetting or a ready-to-use 5% spray-on formulation of dicyclanil over 22 and 31 weeks respectively. Oviposition and strikes were recorded weekly for each sheep. In two field trials the occurrence of strike in Merino sheep treated off-shears or in long wool with dicyclanil or with cyromazine was compared for up to 38 weeks after treatment. Efficacy was assessed by calculating the cumulative percentage of sheep struck. RESULTS: Under environment house conditions, sheep jetted with dicyclanil at 1.50, 0.75 and 0.30 g per sheep developed 0, 8 and 9 strikes respectively during the 22 weeks of the trial, whereas there were 358 strikes present in the placebo group. Sheep sprayed with dicyclanil at 2.25, 1.50 and 0.75 g per sheep developed 5, 11 and 29 strikes respectively between weeks 15 and 31 after treatment, whereas there were 185 strikes present in the untreated controls. In field trials the cumulative percentage of sheep struck reached 1% between weeks 12 to 13 after sheep had been treated with cyromazine. Sheep treated with dicyclanil reached the 1% limit at week 21 after treatment. CONCLUSION: Under Australian field conditions, a ready-to-use 5% spray-on formulation of dicyclanil applied off-shears or to long wool protected Merino sheep from blowfly strike for a period of at least 20 weeks.     

Strategic use of crutching and dicyclanil to protect unmulesed sheep against breech strike

Objective   To test strategies for the application of dicyclanil and mid-season crutching to maximise protection of unmulesed sheep against breech strike.
Procedure   Three hundred and eighty unmulesed Merino weaners were randomly allocated to four groups either left untreated or treated by different strategies with 50 g/L dicyclanil. Treatments included breech treatment alone and breech plus body treatment, with two application times, immediately after shearing and 6 weeks after crutching or shearing. To assess protection, larval implants with newly hatched Lucilia cuprina larvae were applied to 10 different sheep from each group at 3, 4, 5 and 6 months after crutching and shearing and assessed for the development of strike at 48 hours. The concentration of dicyclanil was measured in wool samples clipped from the breeches of the test sheep.
Results   All dicyclanil treatments gave significant reduction in strike in comparison to controls up until 4 months after crutching but protection in the sheep treated immediately after shearing had waned at 5 months. Treating at 6 weeks after crutching provided significant reduction ( P < 0.05) in strike for 6 months. Results for strike incidence immediately after shearing and concentration of dicyclanil in the breech wool also suggested improvements in protection by delaying treatment for 6 weeks.
Conclusion   In most environments it should be possible to protect unmulesed sheep against breech strike with a carefully planned integrated control program incorporating strategically timed crutching, shearing and dicyclanil application. Delaying treatment with dicyclanil to at least 6 weeks after shearing or crutching increased the protection provided in comparison to treatment immediately after shearing.     

Evaluation of dicyclanil (CLiKZiN®) treatment for the early-season protection of ewes against blowfly strike

Protecting sheep against early season myiasis (strike) is a significant problem in northern temperate farming systems, where fully-fleeced ewes and early-season lambs approaching market weight, are at high initial risk. Here, the prevention of early-season blowfly strike in ewes was examined on matched commercial sheep farms in south west England, using a new formulation of dicyclanil (CLiKZiN(?) pour on) with a short withdrawal period of 7 days. The ewes on seven farms received a prophylactic treatment with dicyclanil (CLiKZiN 1.25% pour-on suspension) in April 2011; ewes on three control farms received no treatment. The lambs at all farms remained untreated. No adverse reactions to treatment were recorded. On the treatment farms no ewe strikes were recorded between April and June (10 weeks). On control farms, there were 16 strike cases in ewes over the same period, giving a cumulative incidence of 31 cases per 1000 ewes. On the treatment farms only one lamb was struck whereas at the control farms 10 lamb strikes were recorded. The data demonstrate that CLiKZiN was highly effective at protecting ewes against early season strike-challenge.     

Field trial of the efficacy of dicyclanil for the prevention of wohlfahrtiosis of sheep

Two groups of 40 ewes from each of two flocks were used in a field trial of the efficacy of dicyclanil to protect them against a natural infestation by Wohlfahrtia magnifica larvae, when administered topically as a spray-on formulation. The animals of one group in each flock were treated with dicyclanil and those of the other group were left untreated as controls. The trial lasted 31 weeks and the animals were inspected daily for wohlfahrtiosis. The incidences of wohlfahrtiosis ranged from 17.5 per cent to 20 per cent in the control groups and from 2.5 per cent to 5 per cent in the treated groups, and 77.8 per cent of the infestations were in the genitalia. When compared with the control groups, dicyclanil achieved a 100 per cent reduction of infestation in the treated groups of both flocks for at least 24 weeks, and an 80 per cent reduction for 31 weeks.     

Wohlfahrtiosis in sheep and the role of dicyclanil in its prevention

Wohlfahrtia magnifica is the main agent of traumatic myiasis in the southern Palaearctic zone. It was recorded in outbreak situations in Crete, Greece, for the first time in 1999, causing widespread production losses and considerable concern in the livestock sectors. Most commonly applied curative insecticides, organophosphates and pyrethroids, can kill larvae of W. magnifica, but they do not provide long-term protection from infestation or re-infestation, which would facilitate wound healing. The objective of the present work was to study the seasonal dynamics of sheep wohlfahrtiosis in Crete and to determine the prophylactic efficacy of dicyclanil, an insect growth regulator, against natural infestations by larvae of W. magnifica. Six sheep flocks were studied, three from a semi-intensive husbandry system and three from an extensive husbandry system. Two flocks were kept as untreated controls and also were used to study the disease dynamics. Dicyclanil was strategically applied just to males and young non-milking females in four treatment flocks; milking females in these flocks were not treated. The untreated flocks demonstrated seasonal patterns in case numbers that were associated with changes in climate and husbandry activities, especially reproduction and shearing. Cases were most common on the genitalia (60%) and a greater proportion of males than females were infested. The prophylactic efficacy of dicyclanil in males was up to 91.3% over the entire trial period. Hence the incidence in treated males at 22 weeks, when final infestations were recorded, was 5-10% compared to 45-55% in untreated controls. Moreover, the application of dicyclanil to a limited number of animals per flock (males and non-milking females=c. 15-20% of the flock) significantly reduced the incidence of wohlfahrtiosis even in the untreated animals. Hence, final overall incidences in the treated flocks ranged from 4.5 to 5.5% compared to 13.3-13.4% in the control flocks.     

SELENIUM - RESPONSIVE UNTHRIFTINESS OF YOUNG MERINO SHEEP IN CENTRAL VICTORIA

A trial was carried out to determine whether selenium responsive unthriftiness existed on a property in the Strathbogie ranges of Central Victoria where unthriftiness of young sheep has been a problem for 10 to 20 years. White muscle disease had been diagnosed on the property in the previous year and on other properties in the area. Eighty Merino ewes and lambs were allotted to one of 4 groups in a 2 x 2 factorial designed trial in which sodium selenite (0.1 mg/kg) was given orally to ewes and/or lambs at marking time and to treated lambs at 3 monthly intervals thereafter. Selenium treatment of the ewes had no significant effect on subsequent lamb performance. Selenium treatment of the lambs produced significant responses: mortality in treated groups was 0% compared with 17.5% in untreated groups; body weight gains were 1.9 kg higher at both weaning and one year of age in treated than in untreated lambs; mean fleece weight was 14.4% higher in treated lambs and they produced 39% more wool than the surviving untreated lambs.     

Prevalence of breech-strike in mulesed, clipped and unmulesed Merino hoggets in south-eastern Australia

Objective To compare the prevalence of breech flystrike (‘breech‐strike’) on 12–20‐month‐old Merino hoggets that were mulesed, had breech and tail clips applied (‘clipped’) or were left unmulesed but treated strategically with long‐acting insecticide. Design A cohort study on three farms in southern Victoria. Methods Three treatment groups were established at lamb marking on each farm. The unmulesed group was treated with dicyclanil when 12 months old in September or October (‘early‐season treatment’). The prevalence of breech‐strike and key risk factors, including soiling of the breech with faeces (‘dag’) and urine (‘stain’), and breech wrinkle, were compared between the groups. Results Over all the farms, breech‐strike occurred on 1.1% of mulesed sheep and 7.7% of clipped sheep. Clipped sheep had a relative risk of breech‐strike of 18.2‐, 16.8‐ and 3.0‐fold that of mulesed sheep on the three farms. Unmulesed sheep treated with dicyclanil had a similar prevalence of breech‐strike to that of mulesed sheep (overall 0.9%, range 0–2.5%), but had significantly more dag, stain and wrinkle. Conclusion Early‐season treatment of unmulesed sheep prevented most breech‐strikes during the spring and early summer, and offers a short‐ to medium‐term option for the control of breech‐strike in south‐eastern Australia. There were some benefits associated with using clips, namely less dag and stain, and a shorter time spent crutching. However, to control breech‐strike the clipped sheep should be treated the same as unmulesed sheep. Reducing the prevalence and severity of dag will be a major component of strategies to control breech‐strike of Merinos in this region.     

Efficacy of toltrazuril in the prevention of coccidiosis in naturally infected lambs on pasture

The efficacy of toltrazuril (Bay Vi 9142) in preventing ovine coccidiosis due to an infection acquired immediately after turnout on pasture was evaluated by comparing the faecal consistency, weight gain, and oocyst output of treated and untreated lambs in 3 trials. The lambs were either given a single treatment with toltrazuril at 15 or 20 mg/kg, or they were given a dose of 10 mg/kg on 2 separate days. A single treatment with toltrazuril at 20 mg/kg on day 10 after turnout on pasture almost completely prevented coccidiosis in 2 trials. In a third trial the acute phase of a severe Nematodirus battus infection coincided with the outbreak of coccidiosis, and thus partly masked the clinical effect of the anticoccidial treatment. In lambs treated with toltrazuril at 15 mg/kg on day 10 after turnout, the coccidial infection caused a softening of the faeces, but the lambs were not severely affected by the coccidia. In lambs given a dose of 10 mg/kg of toltrazuril twice, either on days 10 and 11 after turnout, or on days 10 and 20, the coccidial infection caused a softening af the faeces, including some cases of diarrhoea. Oocyst production due to the initial coccidial infection on pasture was markedly reduced by all treatments with toltrazuril. The reduction was most pronounced after a dose of 20 mg/kg. Lambs treated with single doses of 15 or 20 mg/kg of toltrazuril had a better weight gain than the untreated controls in 2 of the trials. Lambs treated with toltrazuril on day 10 after turnout were partially resistant to the coccidial reinfection acquired immediately after treatment, and they had a similar level of immunity as the untreated controls to the subsequent reinfection on pasture.     

Demonstration of the sustained anthelmintic efficacy of a controlled-release capsule formulation of ivermectin in weaner lambs under field conditions in New Zealand

Ten field trials were conducted in the North and South Islands of New Zealand to evaluate the anthelmintic efficacy and production responses attributable to treatment of weaner lambs with an intra-ruminal controlled-release capsule formulation of ivermectin. A total of 800 Coopworth, Perendale and Romney lambs weighing on average 20.8-34.8 kg were used. Lambs were either untreated or treated shortly after weaning with an ivermectin controlled-release capsule which delivers ivermectin at 0.8 mg per day for 100 days (minimum dose rate 20 microg/kg/day). Bodyweights, faecal nematode egg counts and dag scores (assessment of faecal soiling in the breech area) were determined before treatment and at about 4,8, 12, 14 and 16 weeks after treatment. Sheep treated with the Ivermectin capsule gained significantly more weight (11.6 kg) over the 16 weeks of the trials compared to untreated sheep (7.3 kg) (p < 0.01). Before treatment, faecal strongylid and Nematodirus spp. egg counts were equivalent (p > 0.10) but, at each time point thereafter, egg counts in ivermectin capsule-treated sheep were significantly lower (p < 0.01 or p < 0.05). Dag scores were not different at the start of the trial (p > 0.10), but at the end of the trial control sheep had significantly greater dags (p < 0.05) than sheep treated with the ivermectin capsule. These findings indicate that treated animals contributed significantly fewer nematode eggs to the contamination of pasture and therefore pasture contamination should be significantly reduced for at least 112 days. The productivity of the ivermectin capsule-treated sheep over the I6 weeks of the trials was also significantly increased compared to salvage-treated controls. Furthermore, the presence of dags, which predispose sheep to blowfly strike in the breech area and result in production losses due to the costs of dagging and downgrading of breech wool, were also significantly (p < 0.05) reduced in the ivermectin capsule-treated sheep.     

Effectiveness of copper oxide wire particles for Haemonchus contortus control in sheep

OBJECTIVE: To assess the efficacy of copper oxide wire particles (COWP) for the control of H contortus infections in grazing sheep. PROCEDURE: In experiment 1, 40 worm-free Merino hoggets (11 to 12 months of age) were divided into four equal groups and allocated to separate 0.8 ha pasture plots. Two groups then received 2.5 g COWP whereas the other two groups were untreated. From 1 week after COWP treatment all lambs received a weekly infection of 2000 H contortus larvae. At week 8, six sheep from the untreated group were then allocated to two groups and treated with either 2.5 or 5.0 g of COWP to establish therapeutic efficacy of treatment. Experiment 2 followed a similar protocol but was conducted with 40 worm-free Merino lambs (3 to 4 months of age) and no assessment of therapeutic efficacy was made. Results: In experiment 1 no significant difference in faecal worm egg counts was observed between treatments and faecal worm egg counts remained less than 3000 epg in all animals. Total worm counts were reduced by 37% by COWP treatment (P = 0.055). Both 2.5 g and 5.0 g doses of COWP at 8 weeks of infection reduced faecal worm egg counts by > 85% with the higher dose giving an earlier response to treatment. In experiment 2, faecal worm egg counts at 4 and 6 weeks were reduced by more than 90% in the COWP treated lambs and worm numbers were 54% lower after 6 weeks when all remaining untreated lambs had to be treated for haemonchosis. Mean faecal worm egg counts in the COWP lambs remained below 3500 epg and clinical disease did not develop in the majority of lambs before the end of the experiment at 10 weeks. CONCLUSION: Treatment with COWPs appears to have the potential to reduce establishment and worm fecundity of Haemonchus spp for an extended period and may offer livestock producers a supplementary means of reducing larval contamination of pasture particularly in areas where anthelmintic resistance is a problem and copper supplementation is likely to be beneficial.     

Efficacy of levamisole and netobimin against Haemonchus contortus in lambs in Louisiana

Efficacy of levamisole was evaluated in a suspected levamisole-resistant population of Haemonchus contortus in the Louisiana State University sheep flock. The efficacy of netobimin also was evaluated against this population of Haemonchus. In trial 1, 5 lambs naturally infected with H contortus were given 8 mg of levamisole/kg of body weight as a drench, and 5 lambs were not treated (controls). Nematode recovery after slaughter indicated 0% efficacy against H contortus. In trial 2, 30 nematode-free lambs were each given 8,300 F1 generation infective larvae of H contortus, which were derived from parent H contortus that survived 2 levamisole treatments in lambs being maintained in a nematode-free environment. Ten lambs were treated with 8 mg of levamisole/kg as a drench, 10 were treated with 20 mg of netobimin/kg as a drench, and 10 were not treated (control). Nematode recovery after slaughter revealed 62.3% and 99.8% efficacy for levamisole and netobimin, respectively, against H contortus.     

The efficacy of ivermectin jetting fluid for control of blowfly strike on sheep under field conditions

SUMMARY Seventeen trials involving 5737 sheep were conducted to test the efficacy of ivermectin jetting fluid (30 ppm in water) for the control of blowfly strike when applied to sheep either by standard hand jetting or through an automatic jetting race. Sheep were observed for up to 14 weeks after treatment and all strikes recorded. The level of fly challenge varied between trials, resulting in strike rates in untreated sheep ranging between 0 and 94%. At 12 weeks after treatment there were 93% fewer strikes in hand jetted sheep and 84% fewer strikes in machine jetted sheep when compared with untreated sheep. At this time point there was a 90%, 86% and 93% reduction in poll, body and breech strikes, respectively, when hand jetting was used, whereas machine jetting reduced poll, body, breech and pizzle strikes by 84%, 81%, 79% and 100%, respectively.     

Growth response to increasing doses of microencapsulated vitamin B12 and related changes in tissue vitamin B12 concentrations in cobalt-deficient lambs

AIM: To investigate growth response of cobalt deficient lambs to increasing doses of microencapsulated vitamin B12, and to measure associated changes in serum and liver vitamin B12 concentrations over 243 days. METHODS: From a flock grazing pastures that had low cobalt (Co) levels (about 0.06 mg Co/kg dry matter), 4-6-week-old lambs (n=137) were assigned to four groups and received either no treatment or a subcutaneous injection of 3.0, 4.5 or 6.0 mg of microencapsulated vitamin B12 on Day 1. At approximately monthly intervals, all lambs were weighed and blood samples were collected from a selection (n=10) of monitor animals, up to Day 243. Liver biopsies were also carried out on the monitor lambs (n=8) on Days 1, 124 and 215. RESULTS: The vitamin B12-treated lambs grew significantly faster (p<0.001) than untreated animals. Liveweights after 243 days were 28, 45, 45 and 47 kg for the untreated, 3.0, 4.5 and 6.0 mg vitamin B12-treated lambs, respectively. Of the initial group of untreated lambs, 68% had to be removed before the end of the trial because of substantial weight loss, but none of the treated animals were similarly afflicted. Serum vitamin B12 concentrations increased in all vitamin B12-treated lambs, reaching a peak at Day 25, and those of the 4.5 and 6.0 mg vitamin B12-treated lambs remained significantly higher (except at Day 124) than the untreated lambs to Day 187. However, at Day 124, but not Day 215, the liver vitamin B12 concentrations of treated lambs were two to three times higher than those of controls. CONCLUSIONS: The growth rates of Co deficient lambs were markedly improved by injection of 3.0, 4.5 or 6.0 mg of microencapsulated vitamin B12, and liveweights were maintained for at least 243 days. Serum vitamin B12 concentrations were related to this growth response; concentrations of <220 pmol vitamin B12/l were associated with a 95% probability that lambs were Co deficient and would thus respond to Co/vitamin B12 supplementation. Based on these data, the current New Zealand reference criteria for Co deficiency should be reviewed. CLINICAL SIGNIFICANCE: An injection of 3 mg microencapsulated vitamin B12 given to lambs at tailing will treat Co deficiency and will increase and maintain liveweights in a flock for up to 8 months.     

Use of long-acting oxytetracycline against pasteurellosis in lambs

The efficacy of long-acting oxytetracycline in the control of pneumonic pasteurellosis in lambs was tested on seven Scottish farms. After laboratory confirmation of pasteurella-related deaths in lambs, half the lambs in each flock were given long-acting oxytetracycline (20 mg/kg intramuscularly) and half were left untreated. On three farms a single treatment was given and on four farms two doses were administered four days apart. Eighteen of the 878 control lambs died as a result of confirmed Pasteurella haemolytica pneumonia compared with one of the 878 treated lambs. In addition nine of the control lambs were diagnosed clinically to have pasteurellosis which responded to treatment with oxytetracycline. None of the treated lambs were seen to be ill during the trial.     

Effects of leucocyte extract, levamisole and sulphadimidine on natural coccidial infections (Eimeria spp.) in young lambs

The efficacy of leucocyte extract (LE) and sulphadimidine in preventing coccidiosis in naturally infected lambs on pasture was evaluated in 3 separate experiments, whereas the prophylactic effect of levamisole was studied in 1 of the experiments. LE prepared from ewes immune to coccidia (Eimeria spp.) was administered either intravenously or intraperitoneally to young lambs 7, 5, or 2 days before they were turned out on pastures contaminated with coccidia. In all experiments, LE failed to transfer protective immunity to the lambs against the first coccidial infection on pasture. The LE preparations used apparently had an immunosuppressive effect, which resulted in more severe clinical signs of coccidiosis in the recipients. The lambs given LE showed a higher incidence of diarrhoea, a poorer weight gain, a higher mortality, and a higher oocyst output than the untreated control lambs. In lambs treated with sulphadimidine at 200 mg/kg on days 12, 13, and 14 after turnout there was a reduced severity of the coccidial infections in all experiments. The sulphadimidine-treated lambs had better weight gains and passed fewer oocysts than the controls during the third and fourth week after turnout, but some of them developed diarrhoea. Lambs treated with levamisole at 2 mg/kg 2 days before turnout, at turnout, and 2 days after turnout were more severely affected by the first coccidial infection on pasture than the controls.To study the lambs’ immunity against a heavy challenge infection with coccidia as compared with their immunity against the natural reinfection on pasture, some of the lambs from the original groups (untreated, sulphadimidine-treated, LE-treated) were each inoculated with 2 mill. Eimeria spp. oocysts about 6 weeks after turnout. The oocyst counts of the challenged lambs, except the LE-treated lambs, increased to a new peak 19–20 days after challenge. The challenge infection caused a softening of the faeces and a marked depression in weight gain in all challenged groups of lambs, mainly between days 10 and 17 after challenge. The lambs were thus only partially immune to coccidia after the first coccidial infection on pasture. The lambs treated with either LE or sulphadimidine in connection with the first coccidial infection on pasture were not appreciably more susceptible to the challenge infection than the untreated lambs.     

Intramammary antibiotic treatment at the end of lactation for prophylaxis and treatment of intramammary infections in ewes

Ewes treated by intramammary infusion of cephapirin benzathine at the end of lactation were less likely to develop new intramammary infections by early in the next lactation. A controlled clinical trial involving 135 treated ewes and 145 untreated control ewes evaluated the prophylactic and treatment efficacy of intramammary antibiotic treatment of ewes at the time of weaning lambs. Milk samples for bacteriologic examination and identification of intramammary infections were collected at weaning of lambs and 1 to 3 weeks into the subsequent lactation. Untreated ewes were 2.6 times more likely than treated ewes to develop new intramammary infections between sampling times. Existence of an intramammary infection in one mammary gland significantly increased the risk of the other mammary gland becoming infected. Treatment also appeared to be associated with a higher cure rate of existing infections.     

Efficacy of ivermectin in a controlled-release capsule for the control of breech strike in sheep

Objective To investigate the efficacy of ivermectin in an intraruminal controlled-release capsule (CRC) against blowfly strike.
Design Pen and field trials with controls.
Animals Pen studies: Two breech strike trials involving 60 Romney and 60 Merino sheep. One body strike trial using 100 Merino sheep.
Field trials: Eight trials in New Zealand used 1000 Romney and Romney-cross sheep. Fifty Merino lambs in one trial in Australia.
Procedure Pen studies: Sheep were allocated to two equal groups. One was not treated, the other sheep received a CRC that delivered ivermectin at 20 μg/kg/day for 100 days. In the breech strike trials, each animal was given an oral laxative 2 days before exposure to adult Lucilia cuprina . In the body-strike trial, the sheep sheep were kept wet to increase susceptibility prior to the release of blowflies.
Field trials: Fifty or 200 sheep allocated to equal groups of nontreated or treated with the CRC and grazed at pasture exposed to natural blowfly challenge.
Results Pen studies: Breech strikes developed in 24 of 60 controls but in none of 60 CRC-treated sheep. There was a 35% reduction in the number of CRC-treated sheep struck on the body.
Field trials: The average number of breech strikes in CRC-treated sheep was reduced by 86% (P < 0.001). The number of body strikes in the treated groups was a reduced by 27% (P < 0.05).
Conclusion The ivermectin CRC is a useful aid in controlling breech strike, but provides only moderate reduction in the incidence of body strike.